http://www.mersana.com
Mersana Therapeutics, Inc. Company Intro
Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication. As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]
Industry
Healthcare
Mersana Therapeutics, Inc. Headquaters
840 Memorial Drive
Cambridge,02139
United States
Mersana Therapeutics, Inc. Share price
17 May 2023 13:33 GMT
$7.80
0.16 (2.09 %)
Mersana Therapeutics, Inc. Market cap
$867.046 M
WMC RANKING
2024
Mersana Therapeutics, Inc. # 293
BiotechnologyLatest Mersana Therapeutics, Inc. News
12 Feb 2024
Rhenman & Partners Asset Management AB Sells 378300 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Rhenman & Partners Asset Management AB decreased its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 94.6% in the 3rd quarter,...
12 Feb 2024
Rhenman & Partners Asset Management AB Sells 378300 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Rhenman & Partners Asset Management AB decreased its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 94.6% in the 3rd quarter,...
12 Feb 2024
Rhenman & Partners Asset Management AB Sells 378300 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)
Rhenman & Partners Asset Management AB decreased its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 94.6% in the 3rd quarter,...
WMC Market Score
WMC Market to Revenue Score
Mersana Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Mersana Therapeutics, Inc. | USD | $828 | $106,406 | $-105,812 | $8,670M | 293 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Mersana Therapeutics, Inc. | 0.01 | 2.42 | 27.71 | 0 | 0 | 0 | 10.74 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
